tip off
PHARMACEUTICAL BENEFITS SCHEME |

How the battle over biologics helped stall the Trans Pacific Partnership

Deborah Gleeson and Ruth Lopert write: Talks that were meant to finalise the Trans Pacific Partnership wound up in Hawaii late last week without reaching a final deal. Over the last five years, 12 countries – Australia, Brunei, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, the United States and Vietnam – have been [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

A call for clarity in policy around drugs known as “biosimilars”

The Pharmaceutical Benefits Advisory Committee and the Therapeutic Goods Administration have been urged to clarify their policies around “biosimilars” – drugs which act in the same way as patented biological drugs, although they may not be exactly the same. Dr Ruth Lopert, who was the TGA’s Principal Medical Adviser from 2008-2011 and Director of the [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

The Health Wrap: A budget health check; medical school war of words; eyes on Ebola; pharmacy deal dispensed; all things equal

                This week’s Health Wrap is compiled by my colleague Megan Howe, the Sax Institute’s Publications Manager. Enjoy the Wrap and tweet us via @medicalmedia or @meghowe68 if you have any ideas for future issues. By Megan Howe A budget health check The Federal Budget’s impact on health [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

Prof Andrew Wilson announced as new Chair for Pharmaceutical Benefits Advisory Committee (PBAC)

(Note from Melissa Sweet on 24 May: See bottom of post for a comment by Professor Andrew Wilson on his appointment). Health Minister Sussan Ley today announced the appointment of Professor Andrew Wilson as the new Chair of the Pharmaceutical Benefits Advisory Committee (PBAC), the independent expert body whose primary role is to recommend new [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

Memo to Canberra: How are other countries finding billions for health care? Ending fossil fuel subsidies

There’s confusion about what is or isn’t on the table for cuts after Health Minister Sussan Ley conceded the Senate won’t pass increased patient contributions for PBS drugs, but said the $1 billion ‘savings’ will have to be found elsewhere. See more below for how it unfolded. But if the Minister and the Federal Government [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

Not all “Captain Chaos” but much confusion, concern on post-Budget health issues

There’s plenty of confusion, contention and concern emerging still out of last week’s Federal Budget on health, with particular uncertainty around after hours GP services. Here’s a quick wrap on some of the issues – complete with glossy illustration from the government’s (once far more dreary-looking) official Budget website pages. Health doesn’t get a big [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

What’s missing from #Budget15 – a future for Medicare

The impact of rebate freezes, the need for improved access to dental care and medicines and the expansion of private health insurance into primary health care have all been ignored in this Budget as part of the Government’s covert goal to destroy Medicare and reinstate a two-tier health system, according to Tim Woodruff, Vice president, Doctors Reform Society. *** Tim Woodruff [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

Health Budget 2015-16 – underwhelming at best

After the drama of last year’s ‘slash and burn’ Budget, the Abbott Government’s second Federal Budget was designed to underwhelm the health sector and in this respect at least it delivered.  In fact, the lack of organisation at the Department of Health lock-up appeared to bother some groups more than the $2 billion of cuts [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

#Budget2015: Health takes a hit, devil may be in the detail – rolling reactions

Health has taken another hit in the 2015-16 Federal Budget, with nearly $2 billion cut from the health system over the next five years. There’s particular concern around $1 billion in “savings” from a range of flexible funds and grants for preventative health research, chronic disease prevention and rural outreach (click twice to enlarge pic below), [...]

READ MORE
PHARMACEUTICAL BENEFITS SCHEME |

Federal Budget Preview

With the 2015-16 Federal Budget only hours away, Croakey has prepared the following summary of the announcements already made in the health portfolio and compared these against the recommendations made by key organisations in their Federal Budget submissions.   While some of the requests from the sector have already fully or partially met (indicated below) through [...]

READ MORE

Womens Agenda

loading...

Smart Company

loading...

StartupSmart

loading...